Search

everythinglearnresearchcommunity

for

Search:↓

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Surgery is the main treatment for liver hydatidosis, but has risks; albendazole is the most effective drug but can have side effects.

Low zinc levels may be linked to the return of gynecologic cancers.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Dutasteride may help shrink prostate cancer tumors.

A special gel with medicine helps prevent melanoma from coming back after surgery.

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Hair loss can be reversed or even cured using advanced hair restoration techniques, with rare complications like swelling and bleeding.